Amrize Ltd (AMRZ)vsLinde plc Ordinary Shares (LIN)
AMRZ
Amrize Ltd
$49.46
-1.81%
BASIC MATERIALS · Cap: $27.88B
LIN
Linde plc Ordinary Shares
$511.17
-0.00%
BASIC MATERIALS · Cap: $235.18B
Smart Verdict
WallStSmart Research — data-driven comparison
Linde plc Ordinary Shares generates 191% more annual revenue ($34.65B vs $11.91B). LIN leads profitability with a 20.4% profit margin vs 9.7%. AMRZ appears more attractively valued with a PEG of 1.37. LIN earns a higher WallStSmart Score of 62/100 (C+).
AMRZ
Hold49
out of 100
Grade: D+
LIN
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AMRZ.
Margin of Safety
-68.7%
Fair Value
$300.49
Current Price
$511.17
$210.68 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Mega-cap, among the largest globally
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 28.5%
Areas to Watch
4.7% revenue growth
3.6% earnings growth
Distress zone — elevated risk
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AMRZ
The strongest argument for AMRZ centers on Price/Book. PEG of 1.37 suggests the stock is reasonably priced for its growth.
Bull Case : LIN
The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.5%.
Bear Case : AMRZ
The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.
Bear Case : LIN
The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
AMRZ profiles as a value stock while LIN is a mature play — different risk/reward profiles.
LIN is growing revenue faster at 8.2% — sustainability is the question.
LIN generates stronger free cash flow (898M), providing more financial flexibility.
Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LIN scores higher overall (62/100 vs 49/100), backed by strong 20.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amrize Ltd
BASIC MATERIALS · BUILDING MATERIALS · USA
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Visit Website →Linde plc Ordinary Shares
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Visit Website →Compare with Other BUILDING MATERIALS Stocks
Want to dig deeper into these stocks?